Boule Diagnostics AB (BOUL) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.017x

Based on the latest financial reports, Boule Diagnostics AB (BOUL) has a cash flow conversion efficiency ratio of -0.017x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.70 Million ≈ $-290.56K USD) by net assets (Skr161.50 Million ≈ $17.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BOUL market cap overview for the company's overall valuation and market capitalisation.

Boule Diagnostics AB - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how Boule Diagnostics AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Boule Diagnostics AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Boule Diagnostics AB ranked by their cash flow conversion efficiency. Explore Boule Diagnostics AB cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Tian An Australia Ltd AU:TIA	0.083x
Guideline Geo AB (publ) ST:GGEO	0.072x
G3 Global Bhd KLSE:7184	0.253x
BIOEXTRAX AB F:85X0	0.455x
Ep&T Global Ltd AU:EPX	1.053x
Saraswati Griya Lestari Tbk JK:HOTL	-0.001x
Paranapanema S.A SA:PMAM3	-0.002x
Ekiz Kimya Sanayi ve Ticaret AS IS:EKIZ	-0.296x

Annual Cash Flow Conversion Efficiency for Boule Diagnostics AB (2005–2024)

The table below shows the annual cash flow conversion efficiency of Boule Diagnostics AB from 2005 to 2024. View BOUL stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr269.60 Million ≈ $29.01 Million	Skr46.60 Million ≈ $5.01 Million	0.173x	+59.84%
2023-12-31	Skr475.10 Million ≈ $51.13 Million	Skr51.38 Million ≈ $5.53 Million	0.108x	+540.55%
2022-12-31	Skr462.50 Million ≈ $49.77 Million	Skr-11.35 Million ≈ $-1.22 Million	-0.025x	-116.77%
2021-12-31	Skr295.74 Million ≈ $31.83 Million	Skr43.28 Million ≈ $4.66 Million	0.146x	-47.61%
2020-12-31	Skr269.30 Million ≈ $28.98 Million	Skr75.24 Million ≈ $8.10 Million	0.279x	+72.30%
2019-12-31	Skr332.87 Million ≈ $35.82 Million	Skr53.98 Million ≈ $5.81 Million	0.162x	+115.26%
2018-12-31	Skr300.86 Million ≈ $32.38 Million	Skr22.66 Million ≈ $2.44 Million	0.075x	-65.83%
2017-12-31	Skr261.77 Million ≈ $28.17 Million	Skr57.72 Million ≈ $6.21 Million	0.220x	+154.89%
2016-12-31	Skr229.76 Million ≈ $24.73 Million	Skr19.88 Million ≈ $2.14 Million	0.087x	-26.95%
2015-12-31	Skr188.51 Million ≈ $20.29 Million	Skr22.32 Million ≈ $2.40 Million	0.118x	-35.03%
2014-12-31	Skr169.99 Million ≈ $18.29 Million	Skr30.98 Million ≈ $3.33 Million	0.182x	+48.25%
2013-12-31	Skr127.49 Million ≈ $13.72 Million	Skr15.68 Million ≈ $1.69 Million	0.123x	+124.26%
2012-12-31	Skr199.69 Million ≈ $21.49 Million	Skr10.95 Million ≈ $1.18 Million	0.055x	+94.22%
2011-12-31	Skr192.86 Million ≈ $20.75 Million	Skr5.44 Million ≈ $585.86K	0.028x	-77.19%
2010-12-31	Skr130.56 Million ≈ $14.05 Million	Skr16.16 Million ≈ $1.74 Million	0.124x	+52.21%
2009-12-31	Skr100.89 Million ≈ $10.86 Million	Skr8.20 Million ≈ $882.84K	0.081x	+117.31%
2008-12-31	Skr115.22 Million ≈ $12.40 Million	Skr4.31 Million ≈ $463.92K	0.037x	-78.30%
2005-12-31	Skr132.36 Million ≈ $14.24 Million	Skr22.82 Million ≈ $2.46 Million	0.172x	--

About Boule Diagnostics AB

ST:BOUL Sweden Medical Devices

Market Cap

$10.41 Million

Skr96.69 Million SEK

Market Cap Rank

#27059 Global

#585 in Sweden

Share Price

Skr2.49

Change (1 day)

-2.35%

52-Week Range

Skr2.49 - Skr6.48

All Time High

Skr74.05